Before conversion therapy, there were no significant differences between the groups in tumor size (9.51 ± 4.13 cm vs. 10.60 ± 3.89 cm, p = 0.216), baseline AFP levels, CA 19-9, albumin, ALT, AST, bilirubin, hemoglobin, white blood cell count, or platelet count (all p > 0.05). This evidence concerns the gene ALB and neoplasm.